Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an agreement to acquire Electrical Geodesics, Inc. (EGI), a US-based medical device company that designs, develops and commercializes a range of non-invasive technologies used to monitor and interpret brain activity.

ZCube, Research Venture of the pharmaceutical group Zambon, announced the second edition of Open Accelerator, the made-in-Italy fast track acceleration program dedicated to projects in life science fields. Open Accelerator is a 12-steps program providing training to international researchers, scientists and aspiring entrepreneurs that following a selection could receive a seed investment of up to a maximum of 100.000 EUR for each project.

The Digital Health Innovation Platform (d.hip) was established by an alliance between university medicine, industry, and science for the purpose of accelerating the digitalization of medicine and healthcare. The Universitätsklinikum Erlangen, Siemens Healthineers, the Friedrich-Alexander-Universität-Erlangen-Nürnberg, the Fraunhofer Institute for Integrated Circuits IIS, and Medical Valley EMN have signed a memorandum of understanding to this effect.

"Everyone talks? We do" is this year's slogan of the WeDoDigital campaign initiated by the German Chambers of Industry and Commerce - a campaign that aims to honor digital success stories in 2017. Cologne-based, digital healthcare company m.Doc is one of the nationwide winners. The award was given to m.Doc's founder and CEO Admir Kulin at the G20 Young Entrepreneurs' Alliance Summit in Berlin yesterday.

The European Patent Office has honored Dutch product manager Jan van den Boogaart, 57, from Siemens Healthineers, and his Austrian research colleague Prof. Oliver Hayden, 45, with the 2017 European Inventor Award for the method they developed together for the automated identification of malaria.

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart patients. The objective is to recognize serious difficult-to-predict complications as early as possible using the latest methods.

Bayer Grants4Apps® is calling all mature teams, startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and Grants4Apps' experts for one full day. If there is a match, you will be invited to Berlin to pitch your solution, discuss collaboration options and close a deal. Find out, if there is a mutual interest to start a bigger journey.